Shares are also safer play on this than calls, but SENS is expecting FDA nod for Glucose Monitoring System in the coming weeks. If anyone wants to add to this. However, this has been one that has been waiting for FDA approval for a very long time and is often delayed. I started a small starter position on some calls and think Feb calls safer for more time than Jan calls to play the FDA approval. Support around that 2.50 area, previously 2 and lots of resistance at 3 then major at 4 level. I would also wait until it calms down after this run today and see what happens with market tomorrow. Also, some of this could already be priced in.
4 Likes